Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, will be sharing a poster ...

Digital Customer Success Benchmark reveals a striking AI implementation crisis: while 72% of CS teams call AI "critical" by 2026, only 32% run even a single live use case, with just 3% achieving ...

Over two thirds of patients with hidradenitis suppurativa experience fewer flares, new lesions, and improved quality of life while using GLP-1 receptor agonists.